In 38 of 83 patients (45.8%), no increase in S100 levels was observed during radiographically confirmed progression and rising pathological LDH levels, and thus there was no connection between S100 serum levels with the clinical course of the uveal melanoma. Here, S100B is linked to uveal melanoma.